Immutable evidence record · ticker
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541)
Published as observed on 21 August 2026 at 18:15 BST.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has a not yet measurable company news read. Its latest completed weekly trend is negative.
- As of
- 21 Aug 2026, 18:15
- Scope
- company and instrument
- Evidence
- 2 items
- Independent sources
- 0
- Country
- Hong Kong
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- —
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541), 2026-08-21, https://sharemaestro.com/evidence/4178dbc6-ccef-475d-b906-428be264ae0b/
Record checksum 8bf2bed029c63b61e2aea957008ddf7b1334876fd256451ab816e2b134ba9dbb
